FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
Last trade - 00:00- £225.44m
- £227.66m
REG - Faron Pharma. Oy - Notice of Annual General Meeting
AnnouncementREG - Faron Pharma. Oy - Positive EMA Opinion on Orphan Drug Designation
AnnouncementREG - Faron Pharma. Oy - Financial Statement 1 January to 31 December 2024
AnnouncementREG - Faron Pharma. Oy - Annual Report 2024 published
AnnouncementREG - Faron Pharma. Oy - Notice of Financial Statement and Annual Report
AnnouncementREG - Faron Pharma. Oy - Holding(s) in Company
AnnouncementREG - Faron Pharma. Oy - Change of Broker
AnnouncementREG - Faron Pharma. Oy - Holding(s) in Company
AnnouncementREG - Faron Pharma. Oy - Results of Oversubscribed Placing
AnnouncementREG - Faron Pharma. Oy - Proposed Issue and Placing
AnnouncementRCS - Faron Pharma. Oy - Final Patient Identified for BEXMAB Phase II Study
AnnouncementREG - Faron Pharma. Oy - Faron’s Financial Calendar for 2025
AnnouncementRCS - Faron Pharma. Oy - Faron presents BEXMAB data at ASH Annual Meeting
AnnouncementRCS - Faron Pharma. Oy - Interactions with UK Regulatory Authorities
AnnouncementREG - Faron Pharma. Oy - Positive Phase 2 Interim Results from BEXMAB Trial
AnnouncementRCS - Faron Pharma. Oy - Targeting Soluble Clever-1 for Autoimmune Diseases
AnnouncementREG - Faron Pharma. Oy - Shareholders’ Nomination Board
AnnouncementREG - Faron Pharma. Oy - Faron’s Capital Markets Day 2024
AnnouncementRCS - Faron Pharma. Oy - Faron announces Capital Markets Day
Announcement